{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:44:28Z","timestamp":1792115068346,"version":"4.4.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41575-026-01197-6","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:06:22Z","timestamp":1775045182000},"page":"549-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pathophysiology of colitis-associated colorectal cancer"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1418-7921","authenticated-orcid":false,"given":"Clemens","family":"Neufert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.48.4.526","volume":"48","author":"JA Eaden","year":"2001","unstructured":"Eaden, J. A., Abrams, K. R. & Mayberry, J. F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48, 526\u2013535 (2001).","journal-title":"Gut"},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","volume":"323","author":"A Ekbom","year":"1990","unstructured":"Ekbom, A., Helmick, C., Zack, M. & Adami, H. O. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med. 323, 1228\u20131233 (1990).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1053\/j.gastro.2009.01.064","volume":"136","author":"S S\u00f6derlund","year":"2009","unstructured":"S\u00f6derlund, S. et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 136, 1561\u20131567 (2009).","journal-title":"Gastroenterology"},{"key":"1197_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","volume":"642","author":"L Hracs","year":"2025","unstructured":"Hracs, L. et al. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature 642, 458\u2013466 (2025).","journal-title":"Nature"},{"key":"1197_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","volume":"395","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n, O. et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet 395, 123\u2013131 (2020).","journal-title":"Lancet"},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","volume":"5","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n, O. et al. Colorectal cancer in Crohn\u2019s disease: a Scandinavian population-based cohort study. Lancet. Gastroenterol. Hepatol. 5, 475\u2013484 (2020).","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"1197_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2021.12.282","volume":"162","author":"ME Kuenzig","year":"2022","unstructured":"Kuenzig, M. E. et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology 162, 1147\u20131159.e4 (2022).","journal-title":"Gastroenterology"},{"key":"1197_CR8","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390, 2769\u20132778 (2017).","journal-title":"Lancet"},{"key":"1197_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/gutjnl-2017-314190","volume":"68","author":"CR Choi","year":"2019","unstructured":"Choi, C. R. et al. Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study. Gut 68, 414\u2013422 (2019).","journal-title":"Gut"},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","volume":"17","author":"H Gordon","year":"2022","unstructured":"Gordon, H. et al. ECCO guidelines on inflammatory bowel disease and malignancies. J. Crohns Colitis 17, 827\u2013854 (2022).","journal-title":"J. Crohns Colitis"},{"key":"1197_CR11","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1053\/gast.2001.24052","volume":"120","author":"J Askling","year":"2001","unstructured":"Askling, J. et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120, 1356\u20131362 (2001).","journal-title":"Gastroenterology"},{"key":"1197_CR12","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.cgh.2015.04.185","volume":"13","author":"M Fumery","year":"2015","unstructured":"Fumery, M. et al. Detection of dysplasia or cancer in 3.5% of patients with inflammatory bowel disease and colonic strictures. Clin. Gastroenterol. Hepatol. 13, 1770\u20131775 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1197_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","volume":"159","author":"PJ Trivedi","year":"2020","unstructured":"Trivedi, P. J. et al. Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age. Gastroenterology 159, 915\u2013928 (2020).","journal-title":"Gastroenterology"},{"key":"1197_CR14","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","volume":"160","author":"AM Wijnands","year":"2021","unstructured":"Wijnands, A. M. et al. Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis. Gastroenterology 160, 1584\u20131598 (2021).","journal-title":"Gastroenterology"},{"key":"1197_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-023-00492-0","volume":"12","author":"RW Zhou","year":"2023","unstructured":"Zhou, R. W., Harpaz, N., Itzkowitz, S. H. & Parsons, R. E. Molecular mechanisms in colitis-associated colorectal cancer. Oncogenesis 12, 48 (2023).","journal-title":"Oncogenesis"},{"key":"1197_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35592-9","volume":"14","author":"WK Chatila","year":"2023","unstructured":"Chatila, W. K. et al. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nat. Commun. 14, 110 (2023).","journal-title":"Nat. Commun."},{"key":"1197_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/j.gastro.2021.05.063","volume":"161","author":"SK Murthy","year":"2021","unstructured":"Murthy, S. K., Feuerstein, J. D., Nguyen, G. C. & Velayos, F. S. AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review. Gastroenterology 161, 1043\u20131051.e4 (2021).","journal-title":"Gastroenterology"},{"key":"1197_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/gutjnl-2025-335023","volume":"75","author":"JE East","year":"2026","unstructured":"East, J. E. et al. British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease. Gut 75, 442\u2013475 (2026).","journal-title":"Gut"},{"key":"1197_CR19","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/gutjnl-2018-316651","volume":"68","author":"J Stj\u00e4rngrim","year":"2019","unstructured":"Stj\u00e4rngrim, J., Ekbom, A., Hammar, U., Hultcrantz, R. & Forsberg, A. M. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population. Gut 68, 1588\u20131596 (2019).","journal-title":"Gut"},{"key":"1197_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrgastro.2009.162","volume":"6","author":"FDM van Schaik","year":"2009","unstructured":"van Schaik, F. D. M. et al. Endoscopic and pathological aspects of colitis-associated dysplasia. Nat. Rev. Gastroenterol. Hepatol. 6, 671\u2013678 (2009).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1197_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/jgh.16496","volume":"39","author":"M Uchino","year":"2024","unstructured":"Uchino, M. et al. Histological differentiation between sporadic and colitis-associated intestinal cancer in a nationwide study: a propensity-score-matched analysis. J. Gastroenterol. Hepatol. 39, 893\u2013901 (2024).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1197_CR22","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1097\/SLA.0000000000005339","volume":"276","author":"C Lu","year":"2022","unstructured":"Lu, C. et al. Survival outcomes and clinicopathological features in inflammatory bowel disease-associated colorectal cancer: a systematic review and meta-analysis. Ann. Surg. 276, e319\u2013e330 (2022).","journal-title":"Ann. Surg."},{"key":"1197_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","volume":"100","author":"FS Velayos","year":"2005","unstructured":"Velayos, F. S., Terdiman, J. P. & Walsh, J. M. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am. J. Gastroenterol. 100, 1345\u20131353 (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"1197_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.cgh.2008.05.020","volume":"6","author":"T Ullman","year":"2008","unstructured":"Ullman, T. et al. Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin. Gastroenterol. Hepatol. 6, 1225\u20131230 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1197_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000353806","volume":"31","author":"A Lopez","year":"2013","unstructured":"Lopez, A. & Peyrin-Biroulet, L. 5-Aminosalicylic acid and chemoprevention: does it work. Digestive Dis. 31, 248\u2013253 (2013).","journal-title":"Digestive Dis."},{"key":"1197_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.gie.2022.12.005","volume":"97","author":"MTJ Bak","year":"2023","unstructured":"Bak, M. T. J. et al. Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study. Gastrointest. Endosc. 97, 767\u2013779.e6 (2023).","journal-title":"Gastrointest. Endosc."},{"key":"1197_CR27","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/ecco-jcc\/jjad083","volume":"17","author":"M Kabir","year":"2023","unstructured":"Kabir, M. et al. DECIDE: Delphi expert consensus statement on inflammatory bowel disease dysplasia shared management decision-making. J. Crohns Colitis 17, 1652\u20131671 (2023).","journal-title":"J. Crohns Colitis"},{"key":"1197_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gie.2020.06.048","volume":"93","author":"BP Mohan","year":"2021","unstructured":"Mohan, B. P. et al. Endoscopic resection of colon dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis. Gastrointest. Endoscopy 93, 59\u201367.e10 (2021).","journal-title":"Gastrointest. Endoscopy"},{"key":"1197_CR29","first-page":"e151","volume":"19","author":"R Yaeger","year":"2020","unstructured":"Yaeger, R. et al. Systemic chemotherapy for metastatic colitis-associated cancer has a worse outcome than sporadic colorectal cancer: matched case cohort analysis. Clin. Colorectal Cancer 19, e151\u2013e156 (2020).","journal-title":"Clin. Colorectal Cancer"},{"key":"1197_CR30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1200\/JCO.19.01674","volume":"38","author":"H Abu-Sbeih","year":"2020","unstructured":"Abu-Sbeih, H. et al. Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease. J. Clin. Oncol. 38, 576\u2013583 (2020).","journal-title":"J. Clin. Oncol."},{"key":"1197_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","volume":"10","author":"MF Neurath","year":"2025","unstructured":"Neurath, M. F., Artis, D. & Becker, C. The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterol. Hepatol. 10, 573\u2013592 (2025).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1197_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s12276-024-01179-1","volume":"56","author":"J Choi","year":"2024","unstructured":"Choi, J. & Augenlicht, L. H. Intestinal stem cells: guardians of homeostasis in health and aging amid environmental challenges. Exp. Mol. Med. 56, 495\u2013500 (2024).","journal-title":"Exp. Mol. Med."},{"key":"1197_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00000658-198602000-00002","volume":"203","author":"AJ Greenstein","year":"1986","unstructured":"Greenstein, A. J., Heimann, T. M., Sachar, D. B., Slater, G. & Aufses, A. H. J. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann. Surg. 203, 123\u2013128 (1986).","journal-title":"Ann. Surg."},{"key":"1197_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/gutjnl-2018-316191","volume":"68","author":"AM Baker","year":"2019","unstructured":"Baker, A. M. et al. Evolutionary history of human colitis-associated colorectal cancer. Gut 68, 985\u2013995 (2019).","journal-title":"Gut"},{"key":"1197_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1053\/j.gastro.2011.12.004","volume":"142","author":"S Galandiuk","year":"2012","unstructured":"Galandiuk, S. et al. Field cancerization in the intestinal epithelium of patients with Crohn\u2019s ileocolitis. Gastroenterology 142, 855\u2013864.e8 (2012).","journal-title":"Gastroenterology"},{"key":"1197_CR36","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1053\/j.gastro.2008.10.086","volume":"136","author":"SJ Leedham","year":"2009","unstructured":"Leedham, S. J. et al. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 136, 542\u2013550.e6 (2009).","journal-title":"Gastroenterology"},{"key":"1197_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41586-019-1856-1","volume":"577","author":"N Kakiuchi","year":"2020","unstructured":"Kakiuchi, N. et al. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Nature 577, 260\u2013265 (2020).","journal-title":"Nature"},{"key":"1197_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1844-5","volume":"577","author":"K Nanki","year":"2020","unstructured":"Nanki, K. et al. Somatic inflammatory gene mutations in human ulcerative colitis epithelium. Nature 577, 254\u2013259 (2020).","journal-title":"Nature"},{"key":"1197_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41580-022-00538-y","volume":"24","author":"SM van Neerven","year":"2023","unstructured":"van Neerven, S. M. & Vermeulen, L. Cell competition in development, homeostasis and cancer. Nat. Rev. Mol. Cell Biol. 24, 221\u2013236 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1197_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.cell.2020.06.036","volume":"182","author":"S Olafsson","year":"2020","unstructured":"Olafsson, S. et al. Somatic evolution in non-neoplastic IBD-affected colon. Cell 182, 672\u2013684.e11 (2020).","journal-title":"Cell"},{"key":"1197_CR41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-024-08167-5","volume":"636","author":"J Jee","year":"2024","unstructured":"Jee, J. et al. Automated real-world data integration improves cancer outcome prediction. Nature 636, 728\u2013736 (2024).","journal-title":"Nature"},{"key":"1197_CR42","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0016-5085(94)90161-9","volume":"107","author":"TA Brentnall","year":"1994","unstructured":"Brentnall, T. A. et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107, 369\u2013378 (1994).","journal-title":"Gastroenterology"},{"key":"1197_CR43","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJMra1403718","volume":"372","author":"L Beaugerie","year":"2015","unstructured":"Beaugerie, L. & Itzkowitz, S. H. Cancers complicating inflammatory bowel disease. N. Engl. J. Med. 372, 1441\u20131452 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR44","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026096","volume":"6","author":"CM Eischen","year":"2016","unstructured":"Eischen, C. M. Genome stability requires p53. Cold Spring Harb. Perspect. Med. 6, a026096 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1197_CR45","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41588-024-01801-y","volume":"56","author":"MP Verhagen","year":"2024","unstructured":"Verhagen, M. P. et al. Non-stem cell lineages as an alternative origin of intestinal tumorigenesis in the context of inflammation. Nat. Genet. 56, 1456\u20131467 (2024).","journal-title":"Nat. Genet."},{"key":"1197_CR46","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M. & Wallace, M. B. Colorectal cancer. Lancet 394, 1467\u20131480 (2019).","journal-title":"Lancet"},{"key":"1197_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM198809013190901","volume":"319","author":"B Vogelstein","year":"1988","unstructured":"Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525\u2013532 (1988).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759\u2013767 (1990).","journal-title":"Cell"},{"key":"1197_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41586-021-03558-4","volume":"594","author":"SM van Neerven","year":"2021","unstructured":"van Neerven, S. M. et al. Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature 594, 436\u2013441 (2021).","journal-title":"Nature"},{"key":"1197_CR50","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-021-03525-z","volume":"594","author":"DJ Flanagan","year":"2021","unstructured":"Flanagan, D. J. et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature 594, 430\u2013435 (2021).","journal-title":"Nature"},{"key":"1197_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0016-5085(94)90167-8","volume":"107","author":"SE Kern","year":"1994","unstructured":"Kern, S. E. et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 107, 420\u2013428 (1994).","journal-title":"Gastroenterology"},{"key":"1197_CR52","first-page":"2035","volume":"55","author":"L Tarmin","year":"1995","unstructured":"Tarmin, L. et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res. 55, 2035\u20132038 (1995).","journal-title":"Cancer Res."},{"key":"1197_CR53","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1053\/j.gastro.2015.12.036","volume":"150","author":"AI Robles","year":"2016","unstructured":"Robles, A. I. et al. Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology 150, 931\u2013943 (2016).","journal-title":"Gastroenterology"},{"key":"1197_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ebiom.2018.11.034","volume":"39","author":"AD Beggs","year":"2019","unstructured":"Beggs, A. D. et al. Validation of epigenetic markers to identify colitis associated cancer: results of module 1 of the ENDCAP-C study. EBioMedicine 39, 265\u2013271 (2019).","journal-title":"EBioMedicine"},{"key":"1197_CR55","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2300::AID-CNCR5>3.0.CO;2-Q","volume":"78","author":"L Gl\u00f3ria","year":"1996","unstructured":"Gl\u00f3ria, L. et al. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 78, 2300\u20132306 (1996).","journal-title":"Cancer"},{"key":"1197_CR56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.gastro.2021.04.042","volume":"161","author":"K Rajam\u00e4ki","year":"2021","unstructured":"Rajam\u00e4ki, K. et al. Genetic and epigenetic characteristics of inflammatory bowel disease-associated colorectal cancer. Gastroenterology 161, 592\u2013607 (2021).","journal-title":"Gastroenterology"},{"key":"1197_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng.3214","volume":"47","author":"A Sottoriva","year":"2015","unstructured":"Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209\u2013216 (2015).","journal-title":"Nat. Genet."},{"key":"1197_CR58","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"1197_CR59","doi-asserted-by":"publisher","first-page":"969","DOI":"10.18632\/oncotarget.22867","volume":"9","author":"M Fujita","year":"2017","unstructured":"Fujita, M. et al. Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling. Oncotarget 9, 969\u2013981 (2017).","journal-title":"Oncotarget"},{"key":"1197_CR60","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1053\/j.gastro.2007.01.035","volume":"132","author":"K Konishi","year":"2007","unstructured":"Konishi, K. et al. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology 132, 1254\u20131260 (2007).","journal-title":"Gastroenterology"},{"key":"1197_CR61","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/ibd.21526","volume":"17","author":"JA Sanchez","year":"2011","unstructured":"Sanchez, J. A., DeJulius, K. L., Bronner, M., Church, J. M. & Kalady, M. F. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm. Bowel Dis. 17, 1966\u20131970 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"1197_CR62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"1197_CR63","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah, S. C. & Itzkowitz, S. H. Colorectal cancer in Inflammatory bowel disease: mechanisms and management. Gastroenterology 162, 715\u2013730.e3 (2022).","journal-title":"Gastroenterology"},{"key":"1197_CR64","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-17-3713","volume":"24","author":"S Din","year":"2018","unstructured":"Din, S. et al. Mutational analysis identifies therapeutic biomarkers in inflammatory bowel disease-associated colorectal cancers. Clin. Cancer Res. 24, 5133\u20135142 (2018).","journal-title":"Clin. Cancer Res."},{"key":"1197_CR65","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","volume":"103","author":"CE Rubin","year":"1992","unstructured":"Rubin, C. E. et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103, 1611\u20131620 (1992).","journal-title":"Gastroenterology"},{"key":"1197_CR66","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.gastro.2016.04.001","volume":"151","author":"R Yaeger","year":"2016","unstructured":"Yaeger, R. et al. Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease. Gastroenterology 151, 278\u2013287.e276 (2016).","journal-title":"Gastroenterology"},{"key":"1197_CR67","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ibd\/izz171","volume":"26","author":"LK Wanders","year":"2020","unstructured":"Wanders, L. K. et al. IBD-associated dysplastic lesions show more chromosomal instability than sporadic adenomas. Inflamm. Bowel Dis. 26, 167\u2013180 (2020).","journal-title":"Inflamm. Bowel Dis."},{"key":"1197_CR68","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1053\/j.gastro.2017.08.031","volume":"153","author":"J-H Tsai","year":"2017","unstructured":"Tsai, J.-H. et al. Association of aneuploidy and flat dysplasia with development of high-grade dysplasia or colorectal cancer in patients with inflammatory bowel disease. Gastroenterology 153, 1492\u20131495.e4 (2017).","journal-title":"Gastroenterology"},{"key":"1197_CR69","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1016\/j.cell.2023.11.006","volume":"186","author":"CN Heiser","year":"2023","unstructured":"Heiser, C. N. et al. Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors. Cell 186, 5620\u20135637.e16 (2023).","journal-title":"Cell"},{"key":"1197_CR70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-018-0190-3","volume":"558","author":"B Degirmenci","year":"2018","unstructured":"Degirmenci, B., Valenta, T., Dimitrieva, S., Hausmann, G. & Basler, K. GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells. Nature 558, 449\u2013453 (2018).","journal-title":"Nature"},{"key":"1197_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2023.03.004","volume":"30","author":"J Kraiczy","year":"2023","unstructured":"Kraiczy, J. et al. Graded BMP signaling within intestinal crypt architecture directs self-organization of the Wnt-secreting stem cell niche. Cell Stem Cell 30, 433\u2013449.e8 (2023).","journal-title":"Cell Stem Cell"},{"key":"1197_CR72","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","volume":"175","author":"J Kinchen","year":"2018","unstructured":"Kinchen, J. et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell 175, 372\u2013386.e17 (2018).","journal-title":"Cell"},{"key":"1197_CR73","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714\u2013730.e22 (2019).","journal-title":"Cell"},{"key":"1197_CR74","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","volume":"27","author":"M Friedrich","year":"2021","unstructured":"Friedrich, M. et al. IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. Nat. Med. 27, 1970\u20131981 (2021).","journal-title":"Nat. Med."},{"key":"1197_CR75","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350\u20131356 (2015).","journal-title":"Nat. Med."},{"key":"1197_CR76","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","volume":"54","author":"I Joanito","year":"2022","unstructured":"Joanito, I. et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat. Genet. 54, 963\u2013975 (2022).","journal-title":"Nat. Genet."},{"key":"1197_CR77","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-024-07747-9","volume":"633","author":"AJ Cornish","year":"2024","unstructured":"Cornish, A. J. et al. The genomic landscape of 2,023 colorectal cancers. Nature 633, 127\u2013136 (2024).","journal-title":"Nature"},{"key":"1197_CR78","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"1197_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","volume":"633","author":"L Nunes","year":"2024","unstructured":"Nunes, L. et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature 633, 137\u2013146 (2024).","journal-title":"Nature"},{"key":"1197_CR80","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ecco-jcc\/jjy201","volume":"13","author":"S Lovisa","year":"2019","unstructured":"Lovisa, S., Genovese, G. & Danese, S. Role of epithelial-to-mesenchymal transition in inflammatory bowel disease. J. Crohns Colitis 13, 659\u2013668 (2019).","journal-title":"J. Crohns Colitis"},{"key":"1197_CR81","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/j.gastro.2021.11.037","volume":"162","author":"H Kobayashi","year":"2022","unstructured":"Kobayashi, H. et al. The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology 162, 890\u2013906 (2022).","journal-title":"Gastroenterology"},{"key":"1197_CR82","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1197_CR83","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41590-020-0741-2","volume":"21","author":"V Koliaraki","year":"2020","unstructured":"Koliaraki, V., Prados, A., Armaka, M. & Kollias, G. The mesenchymal context in inflammation, immunity and cancer. Nat. Immunol. 21, 974\u2013982 (2020).","journal-title":"Nat. Immunol."},{"key":"1197_CR84","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1172\/JCI63748","volume":"123","author":"C Neufert","year":"2013","unstructured":"Neufert, C. et al. Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. J. Clin. Invest. 123, 1428\u20131443 (2013).","journal-title":"J. Clin. Invest."},{"key":"1197_CR85","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41556-018-0179-z","volume":"20","author":"KJ Lenos","year":"2018","unstructured":"Lenos, K. J. et al. Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer. Nat. Cell Biol. 20, 1193\u20131202 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1197_CR86","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/gutjnl-2019-319200","volume":"69","author":"C Heichler","year":"2020","unstructured":"Heichler, C. et al. STAT3 activation through IL-6\/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis. Gut 69, 1269\u20131282 (2020).","journal-title":"Gut"},{"key":"1197_CR87","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"DVF Tauriello","year":"2018","unstructured":"Tauriello, D. V. F. et al. TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554, 538\u2013543 (2018).","journal-title":"Nature"},{"key":"1197_CR88","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","volume":"22","author":"A Calon","year":"2012","unstructured":"Calon, A. et al. Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571\u2013584 (2012).","journal-title":"Cancer Cell"},{"key":"1197_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22450-3","volume":"12","author":"T Nishina","year":"2021","unstructured":"Nishina, T. et al. Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer. Nat. Commun. 12, 2281 (2021).","journal-title":"Nat. Commun."},{"key":"1197_CR90","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2013.06.017","volume":"24","author":"TL Putoczki","year":"2013","unstructured":"Putoczki, T. L. et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24, 257\u2013271 (2013).","journal-title":"Cancer Cell"},{"key":"1197_CR91","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","volume":"27","author":"P Salama","year":"2009","unstructured":"Salama, P. et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 27, 186\u2013192 (2009).","journal-title":"J. Clin. Oncol."},{"key":"1197_CR92","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2012.03.048","volume":"149","author":"B Hu","year":"2012","unstructured":"Hu, B. et al. Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. Cell 149, 1207\u20131220 (2012).","journal-title":"Cell"},{"key":"1197_CR93","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","volume":"40","author":"AM Nicolas","year":"2022","unstructured":"Nicolas, A. M. et al. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. Cancer Cell 40, 168\u2013184.e13 (2022).","journal-title":"Cancer Cell"},{"key":"1197_CR94","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie, D., Ben-Shmuel, A., Erez, N. & Scherz-Shouval, R. Cancer-associated fibroblasts in the single-cell era. Nat. Cancer 3, 793\u2013807 (2022).","journal-title":"Nat. Cancer"},{"key":"1197_CR95","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","volume":"593","author":"MB Buechler","year":"2021","unstructured":"Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575\u2013579 (2021).","journal-title":"Nature"},{"key":"1197_CR96","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/gutjnl-2020-320777","volume":"70","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis. Gut 70, 1495\u20131506 (2020).","journal-title":"Gut"},{"key":"1197_CR97","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41418-024-01380-9","volume":"32","author":"J K\u00f6nig","year":"2025","unstructured":"K\u00f6nig, J., Rokavec, M., \u00d6ner-Ziegler, M. G., Fei, Y. & Hermeking, H. Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing. Cell Death Differ. 32, 225\u2013241 (2025).","journal-title":"Cell Death Differ."},{"key":"1197_CR98","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2017.11.004","volume":"32","author":"\u00d6 Canli","year":"2017","unstructured":"Canli, \u00d6 et al. Myeloid cell-derived reactive oxygen species induce epithelial mutagenesis. Cancer Cell 32, 869\u2013883.e5 (2017).","journal-title":"Cancer Cell"},{"key":"1197_CR99","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","volume":"15","author":"J Bollrath","year":"2009","unstructured":"Bollrath, J. et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15, 91\u2013102 (2009).","journal-title":"Cancer Cell"},{"key":"1197_CR100","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1053\/j.gastro.2023.01.002","volume":"164","author":"AE Shin","year":"2023","unstructured":"Shin, A. E. et al. F4\/80+Ly6Chigh macrophages lead to cell plasticity and cancer initiation in colitis. Gastroenterology 164, 593\u2013609.e13 (2023).","journal-title":"Gastroenterology"},{"key":"1197_CR101","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ccr.2013.10.009","volume":"24","author":"H Katoh","year":"2013","unstructured":"Katoh, H. et al. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 24, 631\u2013644 (2013).","journal-title":"Cancer Cell"},{"key":"1197_CR102","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174545","volume":"134","author":"TM Bui","year":"2024","unstructured":"Bui, T. M. et al. Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancer. J. Clin. Invest. 134, e174545 (2024).","journal-title":"J. Clin. Invest."},{"key":"1197_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. Nat. Commun. 13, 1742 (2022).","journal-title":"Nat. Commun."},{"key":"1197_CR104","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910681","volume":"12","author":"M Germann","year":"2020","unstructured":"Germann, M. et al. Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGF\u03b2. EMBO Mol. Med. 12, e10681 (2020).","journal-title":"EMBO Mol. Med."},{"key":"1197_CR105","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734\u20134752.e20 (2021).","journal-title":"Cell"},{"key":"1197_CR106","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002297","volume":"9","author":"JP V\u00e4yrynen","year":"2021","unstructured":"V\u00e4yrynen, J. P. et al. Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment. J. Immunother. Cancer 9, e002297 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1197_CR107","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","volume":"186","author":"J Gungabeesoon","year":"2023","unstructured":"Gungabeesoon, J. et al. A neutrophil response linked to tumor control in immunotherapy. Cell 186, 1448\u20131464.e20 (2023).","journal-title":"Cell"},{"key":"1197_CR108","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s, F. et al. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391, 2128\u20132139 (2018).","journal-title":"Lancet"},{"key":"1197_CR109","doi-asserted-by":"publisher","first-page":"225ra28","DOI":"10.1126\/scitranslmed.3007607","volume":"6","author":"S Keerthivasan","year":"2014","unstructured":"Keerthivasan, S. et al. \u03b2-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci. Transl. Med. 6, 225ra28 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1197_CR110","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41590-021-00889-2","volume":"22","author":"J Quandt","year":"2021","unstructured":"Quandt, J. et al. Wnt-\u03b2-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression. Nat. Immunol. 22, 471\u2013484 (2021).","journal-title":"Nat. Immunol."},{"key":"1197_CR111","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41591-023-02372-x","volume":"29","author":"DG Shaw","year":"2023","unstructured":"Shaw, D. G. et al. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat. Med. 29, 1520\u20131529 (2023).","journal-title":"Nat. Med."},{"key":"1197_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626349","volume":"11","author":"F Genua","year":"2021","unstructured":"Genua, F., Raghunathan, V., Jenab, M., Gallagher, W. M. & Hughes, D. J. The role of gut barrier dysfunction and microbiome dysbiosis in colorectal cancer development. Front. Oncol. 11, 626349 (2021).","journal-title":"Front. Oncol."},{"key":"1197_CR113","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11465","volume":"491","author":"SI Grivennikov","year":"2012","unstructured":"Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth. Nature 491, 254\u2013258 (2012).","journal-title":"Nature"},{"key":"1197_CR114","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3748\/wjg.v22.i11.3117","volume":"22","author":"J Landy","year":"2016","unstructured":"Landy, J. et al. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J. Gastroenterol. 22, 3117\u20133126 (2016).","journal-title":"World J. Gastroenterol."},{"key":"1197_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2018.12.002","volume":"45","author":"MF Neurath","year":"2019","unstructured":"Neurath, M. F. IL-23 in inflammatory bowel diseases and colon cancer. Cytokine Growth Factor. Rev. 45, 1\u20138 (2019).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"1197_CR116","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","volume":"71","author":"M Tosolini","year":"2011","unstructured":"Tosolini, M. et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res. 71, 1263\u20131271 (2011).","journal-title":"Cancer Res."},{"key":"1197_CR117","first-page":"694","volume":"9","author":"C Jobin","year":"2012","unstructured":"Jobin, C. Colorectal cancer: CRC \u2014 all about microbial products and barrier function? Nat. Rev. Gastroenterol. Hepatol. 9, 694\u2013696 (2012).","journal-title":"Gastroenterol. Hepatol."},{"key":"1197_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1296783","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps. Front. Immunol. 14, 1296783 (2023).","journal-title":"Front. Immunol."},{"key":"1197_CR119","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3892\/ijo.2016.3340","volume":"48","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer. Int. J. Oncol. 48, 929\u2013936 (2016).","journal-title":"Int. J. Oncol."},{"key":"1197_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015742","volume":"5","author":"MJ Langlois","year":"2010","unstructured":"Langlois, M. J. et al. The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression. PLoS ONE 5, e15742 (2010).","journal-title":"PLoS ONE"},{"key":"1197_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25965-x","volume":"12","author":"S Okumura","year":"2021","unstructured":"Okumura, S. et al. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Nat. Commun. 12, 5674 (2021).","journal-title":"Nat. Commun."},{"key":"1197_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.744606","volume":"11","author":"SM Ahmad Kendong","year":"2021","unstructured":"Ahmad Kendong, S. M., Raja Ali, R. A., Nawawi, K. N. M., Ahmad, H. F. & Mokhtar, N. M. Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer. Front. Cell Infect. Microbiol. 11, 744606 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1197_CR123","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1136\/gutjnl-2024-333378","volume":"73","author":"M Van Hul","year":"2024","unstructured":"Van Hul, M. et al. What defines a healthy gut microbiome. Gut 73, 1893\u20131908 (2024).","journal-title":"Gut"},{"key":"1197_CR124","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59\u201365 (2010).","journal-title":"Nature"},{"key":"1197_CR125","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/gutjnl-2018-318131","volume":"68","author":"T Zuo","year":"2019","unstructured":"Zuo, T. et al. Gut mucosal virome alterations in ulcerative colitis. Gut 68, 1169\u20131179 (2019).","journal-title":"Gut"},{"key":"1197_CR126","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","volume":"160","author":"JM Norman","year":"2015","unstructured":"Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447\u2013460 (2015).","journal-title":"Cell"},{"key":"1197_CR127","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol, H. et al. Fungal microbiota dysbiosis in IBD. Gut 66, 1039\u20131048 (2017).","journal-title":"Gut"},{"key":"1197_CR128","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2276806","volume":"15","author":"A Krawczyk","year":"2023","unstructured":"Krawczyk, A., Gosiewski, T., Zapa\u0142a, B., Kowalska-Duplaga, K. & Salamon, D. Alterations in intestinal Archaea composition in pediatric patients with Crohn\u2019s disease based on next-generation sequencing \u2014 a pilot study. Gut Microbes 15, 2276806 (2023).","journal-title":"Gut Microbes"},{"key":"1197_CR129","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee, M. & Chang, E. B. Inflammatory bowel diseases (IBD) and the microbiome \u2014 searching the crime scene for clues. Gastroenterology 160, 524\u2013537 (2021).","journal-title":"Gastroenterology"},{"key":"1197_CR130","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.immuni.2016.02.007","volume":"44","author":"P Kumar","year":"2016","unstructured":"Kumar, P. et al. Intestinal Interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity 44, 659\u2013671 (2016).","journal-title":"Immunity"},{"key":"1197_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05589-3","volume":"14","author":"H Lin","year":"2023","unstructured":"Lin, H. et al. Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction. Cell Death Dis. 14, 68 (2023).","journal-title":"Cell Death Dis."},{"key":"1197_CR132","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","volume":"185","author":"S Federici","year":"2022","unstructured":"Federici, S. et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 185, 2879\u20132898.e24 (2022).","journal-title":"Cell"},{"key":"1197_CR133","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 25, 679\u2013689 (2019).","journal-title":"Nat. Med."},{"key":"1197_CR134","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","volume":"338","author":"JC Arthur","year":"2012","unstructured":"Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120\u2013123 (2012).","journal-title":"Science"},{"key":"1197_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43329-5","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen, B. et al. Contribution of pks+ E. coli mutations to colorectal carcinogenesis. Nat. Commun. 14, 7827 (2023).","journal-title":"Nat. Commun."},{"key":"1197_CR136","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","volume":"161","author":"Y Cao","year":"2021","unstructured":"Cao, Y. et al. Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p. Gastroenterology 161, 1552\u20131566.e12 (2021).","journal-title":"Gastroenterology"},{"key":"1197_CR137","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","volume":"17","author":"CA Brennan","year":"2019","unstructured":"Brennan, C. A. & Garrett, W. S. Fusobacterium nucleatum \u2014 symbiont, opportunist and oncobacterium. Nat. Rev. Microbiol. 17, 156\u2013166 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"1197_CR138","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-023-03398-7","volume":"80","author":"T Dregelies","year":"2023","unstructured":"Dregelies, T., Haumaier, F., Sterlacci, W., Backert, S. & Vieth, M. Detection of Fusobacterium nucleatum in patients with colitis-associated colorectal cancer. Curr. Microbiol. 80, 293 (2023).","journal-title":"Curr. Microbiol."},{"key":"1197_CR139","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1053\/j.gastro.2017.01.009","volume":"152","author":"H Tsoi","year":"2017","unstructured":"Tsoi, H. et al. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology 152, 1419\u20131433.e5 (2017).","journal-title":"Gastroenterology"},{"key":"1197_CR140","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.gastro.2018.04.028","volume":"155","author":"TNY Kwong","year":"2018","unstructured":"Kwong, T. N. Y. et al. Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer. Gastroenterology 155, 383\u2013390.e8 (2018).","journal-title":"Gastroenterology"},{"key":"1197_CR141","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm3233","volume":"378","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites. Science 378, eabm3233 (2022).","journal-title":"Science"},{"key":"1197_CR142","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41586-025-09025-8","volume":"643","author":"M D\u00edaz-Gay","year":"2025","unstructured":"D\u00edaz-Gay, M. et al. Geographic and age variations in mutational processes in colorectal cancer. Nature 643, 230\u2013240 (2025).","journal-title":"Nature"},{"key":"1197_CR143","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2541-0","volume":"586","author":"E Kadosh","year":"2020","unstructured":"Kadosh, E. et al. The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. Nature 586, 133\u2013138 (2020).","journal-title":"Nature"},{"key":"1197_CR144","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195\u2013206 (2013).","journal-title":"Cell Host Microbe"},{"key":"1197_CR145","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847638","volume":"20","author":"MR Rubinstein","year":"2019","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt\/\u03b2-catenin modulator annexin A1. EMBO Rep. 20, e47638 (2019).","journal-title":"EMBO Rep."},{"key":"1197_CR146","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s42255-022-00558-0","volume":"4","author":"D Ternes","year":"2022","unstructured":"Ternes, D. et al. The gut microbial metabolite formate exacerbates colorectal cancer progression. Nat. Metab. 4, 458\u2013475 (2022).","journal-title":"Nat. Metab."},{"key":"1197_CR147","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344\u2013355 (2015).","journal-title":"Immunity"},{"key":"1197_CR148","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","volume":"565","author":"T Tanoue","year":"2019","unstructured":"Tanoue, T. et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 565, 600\u2013605 (2019).","journal-title":"Nature"},{"key":"1197_CR149","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1136\/gutjnl-2019-320105","volume":"69","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice. Gut 69, 1988\u20131997 (2020).","journal-title":"Gut"},{"key":"1197_CR150","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/gutjnl-2022-328075","volume":"72","author":"A Ralser","year":"2023","unstructured":"Ralser, A. et al. Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Gut 72, 1258\u20131270 (2023).","journal-title":"Gut"},{"key":"1197_CR151","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o, J. L. et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 611, 810\u2013817 (2022).","journal-title":"Nature"},{"key":"1197_CR152","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443\u20131448 (2017).","journal-title":"Science"},{"key":"1197_CR153","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi, A. et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell 39, 708\u2013724.e11 (2021).","journal-title":"Cancer Cell"},{"key":"1197_CR154","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1053\/j.gastro.2020.06.042","volume":"159","author":"OO Coker","year":"2020","unstructured":"Coker, O. O., Wu, W. K. K., Wong, S. H., Sung, J. J. Y. & Yu, J. Altered gut archaea composition and interaction with bacteria are associated with colorectal cancer. Gastroenterology 159, 1459\u20131470.e5 (2020).","journal-title":"Gastroenterology"},{"key":"1197_CR155","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/19490976.2017.1379637","volume":"9","author":"ML Richard","year":"2018","unstructured":"Richard, M. L. et al. Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes 9, 131\u2013142 (2018).","journal-title":"Gut Microbes"},{"key":"1197_CR156","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41586-022-04648-7","volume":"606","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Discovery of bioactive microbial gene products in inflammatory bowel disease. Nature 606, 754\u2013760 (2022).","journal-title":"Nature"},{"key":"1197_CR157","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1056\/NEJMc0904160","volume":"361","author":"J Tol","year":"2009","unstructured":"Tol, J., Nagtegaal, I. D. & Punt, C. J. A. BRAF mutation in metastatic colorectal cancer. N. Engl. J. Med. 361, 98\u201399 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR158","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ibd.20886","volume":"15","author":"MM Claessen","year":"2009","unstructured":"Claessen, M. M. et al. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm. Bowel Dis. 15, 1331\u20131336 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"1197_CR159","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1053\/j.gastro.2010.02.007","volume":"138","author":"S S\u00f6derlund","year":"2010","unstructured":"S\u00f6derlund, S. et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology 138, 1697\u20131703 (2010).","journal-title":"Gastroenterology"},{"key":"1197_CR160","doi-asserted-by":"publisher","first-page":"16514","DOI":"10.1073\/pnas.1323064111","volume":"111","author":"JM Amos-Landgraf","year":"2014","unstructured":"Amos-Landgraf, J. M. et al. Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones. Proc. Natl Acad. Sci. USA.\u00a0111, 16514\u201316519 (2014).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1197_CR161","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2024-332919","volume":"74","author":"MF Neurath","year":"2025","unstructured":"Neurath, M. F., Sands, B. E. & Rieder, F. Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet. Gut 74, 9\u201314 (2025).","journal-title":"Gut"},{"key":"1197_CR162","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jcp.30917","volume":"238","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Gut microbiome in tumorigenesis and therapy of colorectal cancer. J. Cell. Physiol. 238, 94\u2013108 (2023).","journal-title":"J. Cell. Physiol."},{"key":"1197_CR163","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad069","author":"S Itzkowitz","year":"2023","unstructured":"Itzkowitz, S. et al. Assessment of stool DNA markers to detect colorectal neoplasia in patients with inflammatory bowel disease: a multi-site case-control study. J. Crohns Colitis https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad069 (2023).","journal-title":"J. Crohns Colitis"},{"key":"1197_CR164","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2024-333353","volume":"74","author":"I Al Bakir","year":"2025","unstructured":"Al Bakir, I. et al. Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis. Gut 74, 740\u2013751 (2025).","journal-title":"Gut"},{"key":"1197_CR165","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2468-1253(16)30027-9","volume":"1","author":"JH Lee","year":"2016","unstructured":"Lee, J. H. & Wang, T. D. Molecular endoscopy for targeted imaging in the digestive tract. Lancet Gastroenterol. Hepatol. 1, 147\u2013155 (2016).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1197_CR166","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41575-022-00701-y","volume":"20","author":"F Chadebecq","year":"2023","unstructured":"Chadebecq, F., Lovat, L. B. & Stoyanov, D. Artificial intelligence and automation in endoscopy and surgery. Nat. Rev. Gastroenterol. Hepatol. 20, 171\u2013182 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1197_CR167","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.cgh.2024.02.014","volume":"22","author":"AM Wijnands","year":"2024","unstructured":"Wijnands, A. M. et al. Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 22, 1697\u20131708 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1197_CR168","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jnci\/djab106","volume":"114","author":"S Ten Hoorn","year":"2022","unstructured":"Ten Hoorn, S., de Back, T. R., Sommeijer, D. W. & Vermeulen, L. Clinical value of consensus molecular subtypes in colorectal cancer: a systematic review and meta-analysis. J. Natl Cancer Inst. 114, 503\u2013516 (2022).","journal-title":"J. Natl Cancer Inst."},{"key":"1197_CR169","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa2502760","volume":"393","author":"KS Courneya","year":"2025","unstructured":"Courneya, K. S. et al. Structured exercise after adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 393, 13\u201325 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR170","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41571-023-00824-4","volume":"20","author":"AM Tsimberidou","year":"2023","unstructured":"Tsimberidou, A. M. et al. Molecular tumour boards \u2014 current and future considerations for precision oncology. Nat. Rev. Clin. Oncol. 20, 843\u2013863 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1197_CR171","doi-asserted-by":"publisher","first-page":"CLO23-047","DOI":"10.6004\/jnccn.2022.7163","volume":"21","author":"K Desai","year":"2023","unstructured":"Desai, K., Pereira, K., Jain, A., Iqbal, S. & Thirumaran, R. Ivosidenib as a novel treatment for patients with isocitrate dehydrogenase-1 positive advanced colon cancer [abstract]. J. Natl Compr. Cancer Netw. 21, CLO23-047 (2023).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"1197_CR172","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa, G. K. et al. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 21, 796\u2013807 (2020).","journal-title":"Lancet Oncol."},{"key":"1197_CR173","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2504650","volume":"393","author":"A Martling","year":"2025","unstructured":"Martling, A. et al. Low-dose aspirin for PI3K-altered localized colorectal cancer. N. Engl. J. Med. 393, 1051\u20131064 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR174","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/ibd\/izaa060","volume":"27","author":"P Patel","year":"2021","unstructured":"Patel, P. et al. Daily aspirin use does not impact clinical outcomes in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 27, 236\u2013241 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"1197_CR175","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","volume":"384","author":"MM Awad","year":"2021","unstructured":"Awad, M. M. et al. Acquired resistance to KRASG12C inhibition in cancer. N. Engl. J. Med. 384, 2382\u20132393 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07266-5","volume":"15","author":"A Esposito","year":"2024","unstructured":"Esposito, A. et al. Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance. Cell Death Dis. 15, 878 (2024).","journal-title":"Cell Death Dis."},{"key":"1197_CR177","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1136\/gutjnl-2021-326560","volume":"71","author":"C G\u00fcnther","year":"2022","unstructured":"G\u00fcnther, C., Winner, B., Neurath, M. F. & Stappenbeck, T. S. Organoids in gastrointestinal diseases: from experimental models to clinical translation. Gut 71, 1892\u20131908 (2022).","journal-title":"Gut"},{"key":"1197_CR178","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1038\/s41591-024-03083-7","volume":"30","author":"AJ Bullock","year":"2024","unstructured":"Bullock, A. J. et al. Botensilimab plus balstilimab in relapsed\/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial. Nat. Med. 30, 2558\u20132567 (2024).","journal-title":"Nat. Med."},{"key":"1197_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu, B., Zhang, B., Li, B., Wu, H. & Jiang, M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct. Target. Ther. 9, 274 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1197_CR180","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","volume":"21","author":"F Lang","year":"2022","unstructured":"Lang, F., Schr\u00f6rs, B., L\u00f6wer, M., T\u00fcreci, \u00d6 & Sahin, U. Identification of neoantigens for individualized therapeutic cancer vaccines. Nat. Rev. Drug Discov. 21, 261\u2013282 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1197_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02612-0","author":"A Mackensen","year":"2023","unstructured":"Mackensen, A. et al. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-023-02612-0 (2023).","journal-title":"Nat. Med."},{"key":"1197_CR182","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.add7034","volume":"382","author":"RL Vincent","year":"2023","unstructured":"Vincent, R. L. et al. Probiotic-guided CAR-T cells for solid tumor targeting. Science 382, 211\u2013218 (2023).","journal-title":"Science"},{"key":"1197_CR183","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1158\/1078-0432.CCR-23-3841","volume":"30","author":"M Wehrli","year":"2024","unstructured":"Wehrli, M. et al. Mesothelin CAR T cells secreting anti-FAP\/anti-CD3 molecules efficiently target pancreatic adenocarcinoma and its stroma. Clin. Cancer Res. 30, 1859\u20131877 (2024).","journal-title":"Clin. Cancer Res."},{"key":"1197_CR184","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","volume":"13","author":"HF Farin","year":"2023","unstructured":"Farin, H. F. et al. Colorectal cancer organoid\u2013stroma biobank allows subtype-specific assessment of individualized therapy responses. Cancer Discov. 13, 2192\u20132211 (2023).","journal-title":"Cancer Discov."},{"key":"1197_CR185","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1126\/science.aaw2367","volume":"364","author":"WS Garrett","year":"2019","unstructured":"Garrett, W. S. The gut microbiota and colon cancer. Science 364, 1133\u20131135 (2019).","journal-title":"Science"},{"key":"1197_CR186","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2025","unstructured":"Sung, H. et al. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol. 26, 51\u201363 (2025).","journal-title":"Lancet Oncol."},{"key":"1197_CR187","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1136\/gutjnl-2018-317592","volume":"68","author":"FE Vuik","year":"2019","unstructured":"Vuik, F. E. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 68, 1820\u20131826 (2019).","journal-title":"Gut"},{"key":"1197_CR188","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMra2200869","volume":"386","author":"FA Sinicrope","year":"2022","unstructured":"Sinicrope, F. A. Increasing incidence of early-onset colorectal cancer. N. Engl. J. Med. 386, 1547\u20131558 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR189","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","volume":"120","author":"DT Rubin","year":"2025","unstructured":"Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Barnes, E. L. & Long, M. D. ACG clinical guideline update: ulcerative colitis in adults. Am. J. Gastroenterol. 120, 1187\u20131224 (2025).","journal-title":"Am. J. Gastroenterol."},{"key":"1197_CR190","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2021","unstructured":"Raine, T. et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J. Crohns Colitis 16, 2\u201317 (2021).","journal-title":"J. Crohns Colitis"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01197-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01197-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01197-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:24:15Z","timestamp":1782825855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01197-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":190,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1038\/s41575-026-01197-6","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"11 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}